Trial Profile
Phase II, Open-label, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Patients With Severe Cardiac Iron Overload Due to Chronic Blood Transfusion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary) ; Deferoxamine
- Indications Iron overload
- Focus Therapeutic Use
- Acronyms HYPERION
- Sponsors Novartis
- 22 May 2014 According to the Novartis media release, results from this trial presented at the 19th European Hematology Society on 14 June 2014.
- 21 Mar 2014 New trial record